THERAPEUTIC MURINE MONOCLONAL ANTIBODY

摘要

The present invention relates to a monoclonal antibody which is broadly reactive with all normal human peripheral blood mononuclear cells and granulocyte, and to the hybridoma cell line which produces this monoclonal antibody. This monoclonal antibody is designated WM-65 and the hybridoma cell line is designated F56-1D5 (ECACC). This monoclonal antibody reacts with a previously unrecognised human leucocyte surface membrane antigen. The relative molecular mass of the antigen recognised by WM-65 is approximately 40-50 Kilodaltons.